English | Español

Regulatory
+ Regulatory
Patient Daily | Feb 16, 2026

Paragon Health Institute Director: 340B reform ‘would save patients money in premiums and cost sharing’
+ Pharmaceuticals
Patient Daily | Feb 16, 2026

Biopharma job market shows signs of recovery amid broader economic challenges
+ Regulatory
Patient Daily | Feb 16, 2026

PPA Co-founder on 340B’s $54B revenue: ‘The vast majority of that went to hospitals’
+ Pharmaceuticals
Patient Daily | Feb 16, 2026

Researchers trace molecular events linked to Alzheimer's progression
+ Pharmaceuticals
Patient Daily | Feb 16, 2026

Diacerein highlighted as promising adjunct therapy for rheumatoid arthritis
+ Pharmaceuticals
Patient Daily | Feb 16, 2026

University of Illinois study links stronger relationships with better individual health
+ Pharmaceuticals
Patient Daily | Feb 16, 2026

Engineered listeria strain developed at UC Berkeley shows promise as immunotherapy
+ Pharmaceuticals
Patient Daily | Feb 16, 2026

Study links relationship insecurity and materialism to increased phubbing

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns